Application Notes

rHSA Reconstitution Video Protocol

Exbumin – Stabilizing Virus with Albumin to Improve Yield Application Note

Blog

Recombinant Albumin for Stabilization of Live-Attenuated Viral Vaccines

Recombinant Virus Platforms are Out in Front in the Race to Develop Vaccines Against SARS-CoV-2 and COVID-19 Disease

SARS-CoV2 and Influenza – Double Threat

Solving the Vaccine Supply Challenge

The Emergence of Serum-Free Cell Culture Media – Blood-Free Chemically Defined Components

Interviews

Revolutionizing Cell Immunotherapies with Serum Free T Cell Media

Posters

Improving Vaccine Development, Performance, and Stability with Recombinant HSA Excipient

Product Brochures

2021 Product Catalog

SDS

Exbumin – Safety Data Sheet

Use Guidelines

Exbumin – Guidelines for Use

Webinar

Accelerating Vaccine Development Through Use of Blood-Free Components

White Papers

Emergence of Blood-Free Recombinant Human Albumin

Optimization of Albumin Inclusion in Cell Culture Media – Fatty Acid Profiles